Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Procrit in anemic critically ill trauma patients
NCT00210626Phase 2Terminated
- Sponsor
- Johnson & Johnson
- Start
- Aug 2005
- Primary completion
- Jun 2008
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in anemia, sponsored by Johnson & Johnson. Started Aug 2005; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00210626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210626.